David P. Hudesman, MD

  • Specialty: Gastroenterology
  • Language: English
  • Phone: 855-698-4232
Schedule an Appointment

About Me

I was inspired to pursue medicine when I realized it was the best way to combine my interest in science with my desire to help others. As the medical director of the Inflammatory Bowel Disease Center, I specialize in the diagnosis and treatment of inflammatory bowel disease and in endoscopic procedures such as colonoscopy, chromoendoscopy, capsule endoscopy, and upper endoscopy.  

I chose to specialize in the treatment and care of people with inflammatory bowel disease, which primarily includes Crohn’s disease and ulcerative colitis, because this was an area of medicine in which I felt I could make a significant and meaningful difference for my patients and in the overall advancement of research and science. 

Inflammatory bowel disease is a chronic condition, so I have the privilege of caring for my patients for long periods of time. This allows me to develop strong, long-term relationships. Getting to know my patients in this way and helping them to become and remain healthy are my favorite parts of being a physician. 

At the Inflammatory Bowel Disease Center at NYU Langone, we believe it’s important not only to treat the disease but also to care for the whole person. This is why we work in partnership with our patients—to ensure they receive the most effective treatment and care. We provide the latest advances in treatment options, as well as the coordination of nutrition, support groups, acupuncture, surgery (if needed), and other services to ensure that the comprehensive care we provide helps improve all aspects of people’s lives.

Inflammatory bowel disease represents a complex interaction between genetics, gut bacteria, the body’s immune system, and the environment. My research focuses on promising new treatment options for people with Crohn’s disease and ulcerative colitis. I’m also looking at the role of the gut microbiome in the potential prevention, diagnosis, and treatment of these diseases.


Conditions and Treatments

inflammatory bowel disease, Crohn's disease, ulcerative colitis, colorectal cancer screening, colonoscopy

Credentials

Positions
  • Associate Professor, Department of Medicine
  • Medical Director, Inflammatory Bowel Disease Center, NYU Langone Health
Board Certifications
  • American Board of Internal Medicine (Gastroenterology), 2011
  • American Board of Internal Medicine - Internal Medicine, 2008
Education and Training
  • Fellowship, Beth Israel Medical Center (New York, NY), 2011
  • Residency, Mount Sinai Hospital, Internal Medicne, 2008
  • MD from Univ. Medicine & Dentistry NJ, 2005
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • APWA
    • Apwu Health Plan
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna International
    • Aetna Medicare Managed Care
    • Aetna Meritain Health
    • Aetna Open Access Elect Choice (EPO)
    • Aetna Open Access HMO
    • Aetna POS
    • Aetna PPO
    • Aetna Student Health
    • Allied
    • Chesterfield Resources Inc
    • Christian Brothers Services
    • CoreSource
    • Healthscope
    • Nippon Life of America—Aetna
    • Starmark
    • WellNet
  • Blue Cross Blue Shield
    • BCBS EPO
    • BCBS Federal Program
    • BCBS HMO
    • BCBS Indemnity
    • BCBS Mediblue Medicare HMO
    • BCBS Mediblue Medicare PPO
    • BCBS POS
    • BCBS PPO
    • BCBS Pathway
    • BCBS Pathway Enhanced
    • BCBS Pathway X Enhanced
    • Local 32BJ SEIU
    • Unicare
  • Cigna
    • Cigna Great West PPO
    • Cigna HMO
    • Cigna Indemnity
    • Cigna Managed Care/POS
    • Cigna NALC
    • Cigna Open Access
    • Cigna Open Access PPO
    • Cigna PPO
    • Cigna Premier Plus
    • Consolidated Health Plans-NYU Student
    • Great West HMO
    • MVP-Cigna Network
  • Connecticare
    • Connecticare Commercial
  • Emblem
    • Emblem Select Care Bronze Exchange
    • Emblem Select Care Silver Exchange
  • Empire BCBS Health Plus
    • BCBS Healthplus Essential Plan 1
    • BCBS Healthplus Essential Plan 2
    • BCBS Healthplus Essential Plan 3
    • BCBS Healthplus Essential Plan 4
  • GHI
    • American Plan Administrators
    • GHI Emblem Health EPO
    • GHI Emblem Health PPO
    • GHI HMO
    • GHI HMO Medicare
    • GHI Medicare PPO
    • GHI Medicare Supplement
    • IUOE Local 14-14B
    • Wlny-TV Inc.
  • HIP
    • Emblem Essential Plan 1
    • Emblem Essential Plan 2
    • Emblem Essential Plan 3
    • Emblem Essential Plan 4
    • HIP Access I
    • HIP Access II
    • HIP Child Health Plus
    • HIP EPO
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
    • HIP Prime Basic
    • HIP Prime Bronze
    • HIP Prime Gold
    • HIP Prime Platinum
    • HIP Prime Silver
    • HIP Vytra Healthcare Managed Care
    • HIP Vytra Healthcare POS
    • HIP Vytra Healthcare PPO
  • Local 1199
    • Local 1199 NYU Member Choice
    • Local 1199 PPO
  • Magnacare
    • Magnacare PPO
  • Medicare
    • Medicare Part A
    • Medicare Part A and B
    • Medicare Part B
  • Metroplus
    • Metroplus Bronze Plus Plan Exchange
    • Metroplus Child Health Plus
    • Metroplus Essential Plan 1
    • Metroplus Essential Plan 2
    • Metroplus Essential Plan 3
    • Metroplus Essential Plan 4
    • Metroplus Gold
    • Metroplus Gold Plus Plan Exchange
    • Metroplus Medicaid Managed Care
    • Metroplus Medicare
    • Metroplus Medplus Plan Exchange
    • Metroplus Platinum Plus Plan Exchange
    • Metroplus Silver Plus Plan Exchange
  • Multiplan
    • AXA Assistance USA
    • Administrative Concepts
    • Beech Street PPO
    • Diversified Administration Corporation
    • Fiserv Health
    • GEHA
    • Global Excel
    • Global Health
    • Guardian Life Insurance Co Of America
    • Health Net Of California
    • Health Republic Of NJ
    • Humana Health Plan
    • Insurance Design Administrators
    • Kaiser Foundation
    • Kaiser Permanente
    • Meritain Health
    • Multiplan PPO
    • Multiplan—Capital Dist Phys Health
    • Mutual Of Omaha
    • Nippon Life Ins Co
    • PHCS
    • Principal Financial Group
    • Professional Benefit Admin
    • Qualcare Inc
    • Screen Actors Guild
    • Teamsters Allied Benefits
    • US Life Insurance Company
  • NYSHIP - The Empire Plan
    • NYS Health Insurance Plan - The Empire Plan
  • Oxford
    • Oxford Health Plans Freedom
    • Oxford Health Plans Liberty
  • POMCO Insurance Company
    • POMCO Insurance Company
  • Qualcare Inc.
    • Qualcare Direct
  • Railroad Medicare
    • Palmetto GBA Railroad Medicare
  • United Healthcare
    • AARP Medicare Complete
    • Oxford Health Plans Medicare Advantage
    • UMR
    • United Health Care Options PPO (NYU Langone Health Employees)
    • United Healthcare AARP
    • United Healthcare Choice
    • United Healthcare Choice (NYU Langone Health Employees)
    • United Healthcare Choice NSLIJ
    • United Healthcare EPO
    • United Healthcare HMO
    • United Healthcare Inde
    • United Healthcare JP Morgan
    • United Healthcare Medicare
    • United Healthcare Navigate
    • United Healthcare POS
    • United Healthcare PPO
    • United Healthcare Student Resources
  • United Healthcare Community
    • United Community Essential Plan 1
    • United Community Essential Plan 2
    • United Community Essential Plan 3
    • United Community Essential Plan 4
    • United Healthcare Community Child Health Plus
    • United Healthcare Community Medicaid Hmo
    • United Healthcare Community Medicare
  • Wellcare
    • WellCare Child Health Plus
    • WellCare Medicaid Managed Care
    • WellCare Medicare
    • Wellcare Essential Plan 1
    • Wellcare Essential Plan 2
    • Wellcare Essential Plan 3
    • Wellcare Essential Plan 4
NYU Gastroenterology Associates

240 East 38th Street, 23rd Floor
New York, NY 10016

Phone

855-698-4232

Schedule Online

Clinical Trials and Research Studies

  • TARGET-IBD: A 5-year longitudinal observational study of patients undergoing therapy for inflammatory bowel disease (IBD)

    Learn More
  • A Multicenter Randomized Double-Blind Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991

    Learn More
View All Research Studies (2)

Publications

  • Pineles, David; Malter, Lisa; Liang, Peter S; Arsuaga, Amy; Bosworth, Brian; Hudesman, David P; Chang, Shannon

    European journal of clinical pharamacology. 2018 Oct 02; 74(10):1361-1362

  • Corticosteroid use is not associated with decreased length of stay in patients hospitalized with crohn's associated small bowel obstruction [Meeting Abstract]

    Quarta, G; Tanawala, S; Liu, Y; Chang, S; Malter, L; Dikman, A; Hudesman, D

    American journal of gastroenterology. 2018 February; Conference:(2018):S22-S23

  • The use of alvimopan as prophylaxis against post-operative ileus afer bowel resection in patients with inflammatory bowel disease [Meeting Abstract]

    Jang, J; Kwok, B; Grucela, A; Bernstein, M; Remzi, F; Hudesman, D; Chen, J; Chang, S

    American journal of gastroenterology. 2018 February; Conference:(2018):S1-S2

Read All Publications (26)

Related News